Article: Daratumumab news at EHA 2019: promising results in transplant-eligible multiple myeloma patients and a more convenient subcutaneous drug formulation

2.42

SKU: product-article-17493 Category:

Description

Daratumumab news at EHA 2019: promising results in transplant-eligible multiple myeloma patients and a more convenient subcutaneous drug formulation

Reviews

There are no reviews yet.

Be the first to review “Article: Daratumumab news at EHA 2019: promising results in transplant-eligible multiple myeloma patients and a more convenient subcutaneous drug formulation”

Your email address will not be published. Required fields are marked *